FunGen-AD–supported study finds proteins in the blood that link COVID-19 to Alzheimer’s disease and may help predict COVID-19 severity

Researchers at the Washington University School of Medicine in St. Louis studied blood plasma samples from COVID-19 patients and identified proteins that may help predict which patients may need to be placed on ventilators to breathe and which are most likely to die of the virus. The team, led by FunGen-AD researcher Carlos Cruchaga, also found that some of the proteins impacted by COVID-19 infection were linked to coronary artery disease and Alzheimer’s disease pathways, providing insight into the previously observed link between COVID-19 and these diseases.

The research was partially supported by FunGen-AD grant RF1AG058501 and published in iScience here. You can read more about the research findings at the following links: